Wacker Neuson NA buy Covacoro
Start price
08.07.21
/
70%
€24.78
Target price
08.07.22
€32.00
Performance (%)
-15.74%
End price
02.03.22
€20.88
Summary
This prediction ended on 02.03.22 with a price of €20.88. The price of Wacker Neuson NA has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -15.74%. Covacoro has 70% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Wacker Neuson NA | -0.236% | -0.236% | -23.521% |
iShares Core DAX® | -0.922% | -1.993% | 13.399% |
iShares Nasdaq 100 | 0.371% | -0.868% | 41.541% |
iShares Nikkei 225® | 2.224% | -5.187% | 20.497% |
iShares S&P 500 | -0.026% | -0.918% | 30.410% |
According to Covacoro what are the pros and cons of Wacker Neuson NA for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Innovative
EBIT growth >5% per year expected
Undervalued
Capable Management
Cons
Comments by Covacoro for this prediction
In the thread Wacker Neuson NA diskutieren
Covacoro hat das Wertpapier Wacker Neuson NA in seinem Wikifolio COVACORO gekauft.
Kursziel gesetzt auf 28,0
Kursziel geändert auf 32,0
Kursziel geändert auf 0,0
Kursziel gesetzt auf 32,0
In the thread Trading Wacker Neuson NA
Buy beendet
Stopped prediction by Covacoro for Wacker Neuson NA
Wacker Neuson NA
Start price
Target price
Perf. (%)
€16.46
28.11.23
28.11.23
€26.00
28.12.25
28.12.25
6.80%
09.12.23
09.12.23
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Innovative
EBIT growth >5% per year expected
Wacker Neuson NA
Start price
Target price
Perf. (%)
€21.75
17.04.23
17.04.23
€25.00
17.04.24
17.04.24
2.99%
29.04.23
29.04.23
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Innovative
EBIT growth >5% per year expected
Wacker Neuson NA
Start price
Target price
Perf. (%)
€22.62
02.05.21
02.05.21
€30.00
02.05.22
02.05.22
10.43%
15.05.21
15.05.21
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Innovative
EBIT growth >5% per year expected